| Genes |
|---|
| CRX |
| IMPDH1 |
| OTX2 |
| AIPL1 |
| CABP4 |
| CEP290 |
| CRB1 |
| DTHD1 |
| GDF6 |
| GUCY2D |
| IFT140 |
| IQCB1 |
| KCNJ13 |
| LCA5 |
| LRAT |
| NMNAT1 |
| PRPH2 |
| RD3 |
| RDH12 |
| RPE65 |
| RPGRIP1 |
| SPATA7 |
| TULP1 |
| Genes |
|---|
| CRX |
| IMPDH1 |
| OTX2 |
| AIPL1 |
| CABP4 |
| CEP290 |
| CRB1 |
| DTHD1 |
| GDF6 |
| GUCY2D |
| IFT140 |
| IQCB1 |
| KCNJ13 |
| LCA5 |
| LRAT |
| NMNAT1 |
| PRPH2 |
| RD3 |
| RDH12 |
| RPE65 |
| RPGRIP1 |
| SPATA7 |
| TULP1 |
We are majority owned and supported by Centrillion Technologies, a Palo Alto, CA-based company that aspires to complete the work of the Human Genome Project and help scientists efficiently characterize and analyze large segments of the genome to power previously unimaginable breakthroughs in human health and the environment.
© 2024 Molecular Vision Laboratory. All Rights Reserved.